HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

计划入组 30 人 · 首次发布于 2025 年 2 月 13 日

Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy

计划入组 10 人 · 首次发布于 2023 年 8 月 14 日

PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)

计划入组 37 人 · 首次发布于 2018 年 9 月 5 日

Motexafin lutetium

C₅₂H₇₂LuN₅O₁₄

human embryonic stem cell-based therapy (Jeil)

CRISPR/CasX based gene therapy (Biogen/Scribe Therapeutics)

EVIDENCE-BASED PRACTICE INSTITUTE, INC.

United States

METABOLIC THERAPY, INC.

United States

National Evidence-based Healthcare Collaborating Agency

South Korea

Nucs AI Partners with AstraZeneca to Develop AI-Driven Response Prediction for PSMA-Targeted Radioconjugates

Lutetium-PSMA Combination Therapies Show Promise in Advanced Prostate Cancer

PYLARIFY Becomes First Blockbuster Radiodiagnostic with $1.06 Billion in 2024 Sales